Presentation is loading. Please wait.

Presentation is loading. Please wait.

Who is at the highest risk? 3 points each – Cancer – Prior VTE – Hypercoagulability 2 points – Major surgery 1 point each – Age >70 – Obesity (BMI >29)

Similar presentations


Presentation on theme: "Who is at the highest risk? 3 points each – Cancer – Prior VTE – Hypercoagulability 2 points – Major surgery 1 point each – Age >70 – Obesity (BMI >29)"— Presentation transcript:

1 Who is at the highest risk? 3 points each – Cancer – Prior VTE – Hypercoagulability 2 points – Major surgery 1 point each – Age >70 – Obesity (BMI >29) – Bed rest – HRT or COC Increased risk >4 points at any time point after admission Kucher, N. et al. N Engl J Med 2005;352:

2

3 Simplified PESI Retrospective analysis of RIETE registry – Age >801 p –History of Cancer 1 p –Chron cardiopulmonary dis.1 p –Pulse >110 1 p –CHF1 p –SBP <100 1 p –SaO 2 <90%1 p 0 = low risk, 1 or more = high risk Jiménez D et al. Arch Intern Med. 2010;170:1383-9

4 Summary Diagnostic Rules PESI/sPESI most validated – 7 items HESTIA more complex – 11 items ESC is minimalistic, although requires asessment of RV dysfunction, perhaps more dependent on how the physician assesses

5 Acute treatment algorithm Hemodynamic Instability (shock) t-PA Large PE But stable Heparin IV  LMWH Submassive PE Rivaroxaban 15 mg bid  20 mg q.d. Vitamin K antagonist LMWH therap dose  cancer

6 Rivaroxaban - Important to know Starting dose 15 mg BID Switch after 3 weeks to 20 mg daily Must be taken with food Tablets contain lactose (some get stomach pain) Severe renal failure (CrCl <30 mL/min) or concomitant ketokonazole or other azoles, rifampicin and ritonavir are contraindications Few of the study patients hade extensive DVT or large PE. These patients might benefit from intial parenteral Rx.


Download ppt "Who is at the highest risk? 3 points each – Cancer – Prior VTE – Hypercoagulability 2 points – Major surgery 1 point each – Age >70 – Obesity (BMI >29)"

Similar presentations


Ads by Google